Page 



Field P: Duration of Treatment; Time between Administration of 



the Test Compound and a Secondary Compound 99 



Field Q: Size of Inoculum or Implant 103 



Field R: Time of Treatment Relative to Inoculation, Tumor Implantation, 



Sensitization, or Incitation of Non-infectious Pathology 105 



Field S: Route and Manner of Administration of the Inoculum or 



Implant (Field S-l), of the Secondary Compound (Field 



S-2), and of the Test Compound (Field S-3) 108 



Field T: Effect of the Test Compound; General Introduction and Discussion 113 



Field T-l: Action of the Test Compound on the Biological 



State, Quality, or Process Coded in Field T-2 114 



Field T-2: Biological State, Quality, or Process Acted on 



or Produced by the Test Compound or Secondary 



Compound 133 



Field T-3: Category of the Test Compound's Effect, 



Representing Practical Use 155 



Field U: Miscellaneous Time Values: Duration of Response to the Test 

 Compound; Alteration of the Survival Time by the Test Com- 

 pound; Time to Any Response to the Test Compound other than 

 Death; Killing Time of the Test Compound; and Persistence of 

 Activity of a Residue of the Test Compound 1 58 



Field V: Time to Evaluation of the Response to the Test Compound 168 



Fields W, X, and Y: Criterion for Evaluation (Field X); Evaluation: 



Negative Response or Degree of Positive Response 



at the Coded Dosage (Field Y), and Qualification 



of the Negative and Positive Character of Test 



Results (Field W) 17 1 



- tv - 



